Introduction Many women with benign pelvic masses, suspected of ovarian cancer, are
unnecessarily referred for treatment at specialized centers. There is an unmet clinical need …

Ovarian cancer is the most prevalent gynecological malignancy affecting women throughout
the globe. Ovarian cancer has several subtypes, including epithelial ovarian cancer (EOC) …

CA125/MUC16 is an ovarian tumor cell marker widely used as a biomarker in epithelial
ovarian carcinoma. CA125/MUC16 is also used for evaluation of the ROMA (Risk of Ovarian …

Epithelial ovarian cancer (EOC) is one of the leading cancers in women, with high-grade
serous ovarian cancer (HGSOC) being the most common and lethal subtype of this disease …

Background We aim to determine the diagnostic accuracy of both serum and urinary human
epididymis protein 4 (HE4) in the diagnosis of ovarian cancer. Methods Electronic …

Aim. To evaluate the diagnosis value of serum human epididymis protein 4 (HE4), cancer
antigen 125 (CA125), the Risk of Ovarian Malignancy Algorithm (ROMA), and Copenhagen …

Objectives: In order to improve the early diagnosis of ovarian cancer (OC), we evaluated
human epididymis secretory protein 4 (HE4), the risk of malignancy index (RMI), the risk of …

МІНІСТЕРСТВО ОХОРОНИ ЗДОРОВ’Я УКРАЇНИ ІВАНО-ФРАНКІВСЬКИЙ НАЦІОНАЛЬ
Page 1 1 МІНІСТЕРСТВО ОХОРОНИ ЗДОРОВ’Я УКРАЇНИ ІВАНО-ФРАНКІВСЬКИЙ …

Background: Adnexal masses are common presentation among gynecological practice.
Differentiation of benign than malignant lesions is of utmost importance for treatment plan …

Celem badań przedstawionych w poniższej rozprawie doktorskiej było skonstruowanie
nowego panelu analitycznego jako instrumentu do oznaczeń wybranych biomarkerów w …